国产格列美脲治疗2型糖尿病的临床分析(1)
摘要:目的: 探讨国产格列美脲治疗2型糖尿病的临床效果。方法: 本次医学研究选择我院内分泌科2014年1月至2015年1月之间收治的300例2型糖尿病患者为观察对象,随机将其划分为格列美脲组和格列本脲组,分别接受两种药物治疗,对比分析两组2型糖尿病患者的临床治疗效果。结果: 两组2型糖尿病患者接受格列美脲和格列本脲治疗后,各项观察指标结果都显著改善,但两组结果对比仍然无明显的统计学差异(P>0.05)。格列美脲组患者临床治疗后不良反应发生率明显低于格列本脲组(P<0.05)。结论: 本次医学研究结果证实,2型糖尿病患者接受国产格列美脲治疗,降压效果与格列本脲对比无显著差异,但治疗的安全性更高。关键词:国产;格列美脲;2型糖尿病;临床价值
Abstract : Objective: To discuss the clinical effect of treating 2-diabetes mellitus with glimepiride. Methods: Choosed 300 2-diabetes mellitus patients from Jan. 2014 to Jan. 2015 to divide into glimepiride group and glibenclamide group. Compared the clinical effect of these two groups. Results: The results of these two groups were no difference (p>0.05). But the adverse effects of glimepiride group was lower than glibenclamide group (P<0.05). Conclusion: Treating 2-diabetes mellitus with glimepiride is effective as the same as glibenclamide with high safety.
Keywords: glimepiride ......
您现在查看是摘要页,全文长 3910 字符。